Discussion: View Thread

Back to discussions
Expand all | Collapse all

co-sponsoring JSM sessions

  • 1.  co-sponsoring JSM sessions

    Posted 04-26-2011 09:52
    Dear CAS,  Christy was kind enough to forward the email below.  Please take a look at the JSM program and see if there are any sessions you feel we should sponsor.  Is anyone willing to take the lead on this?  Thanks, Jennifer

    --------------------------------------


    Dear Committee Chairs:

    I received the following message from the JSM Meeting Department -

    "Only a few ASA committees have requested cosponsoring JSM session in the past. Please know, we would be happy for any ASA Committees to review the online program and let us know to which sessions they would like to add their cosponsorship.

    If you find that any of the ASA committees under the Membership Council wish to add their group as a cosponsor, they should send an email to meetings@amsstat.org listing any sessions they would like to cosponsor. We ask that they include the session #, Title and primary sponsor in the list.

    We are currently working on changes to the program from the speaker confirmation emails sent out in the past two weeks, but hope to have all changes made and cosponsors added by the end of this month.

    Please let me know if you have any further questions.

     

    Thank you,

    Kathleen

     

     

    Director of Meetings"


    Please take a look at the on-line JSM program (available now) and see if your committee wants to co-sponsor some sessions. If yes, please send the information requested in Kathleen's note to meetings@amstat.org.

    Thanks much,
    -------------------------------------------
    Christy Chuang-Stein
    Pfizer Inc
    -------------------------------------------

    -------------------------------------------
    Jennifer Gauvin

    -------------------------------------------


  • 2.  RE:co-sponsoring JSM sessions

    Posted 04-26-2011 13:50

    Hey everyone,

    Asking one person to take the lead in reviewing the JSM program would be a big job for anyone.  Thanks to Christy for pointing this out to me.

    Could we agree to each do some of the review?  How about the following?

    Invited Topic Contributed
    Sun 7/31 Mark Greg
    Mon 8/1 Amarjot Jack
    Tues 8/2 Keith Erin
    Wed 8/3 Barbara Marlene
    Thurs 8/4 Jennifer Jennifer

    What does that mean?  I will look strictly at Thursday and only Invited and Topic Contributed sessions.  Erin, for example, would look only at Tuesday and only at Topic Contributed sessions.  etc.

    Could we set May 6th as our "deadline"?  Post to our egroup those sessions you think CAS should co-sponsor.  I can then send one email on to ASA meetings on behalf of the committee.

    I did not include Contributed sessions in our review but please do feel free to review if you wish.

    Thanks!
    Jennifer




    -------------------------------------------
    Jennifer Gauvin
    Manager, Statistics
    GlaxoSmithKline
    -------------------------------------------








  • 3.  RE:co-sponsoring JSM sessions

    Posted 04-26-2011 13:57

    I'll take what you proposed...if someone needs help, let me know, as I'd be willing to take a 2nd block.

    -------------------------------------------
    Keith Schleicher
    Capital One Services, Inc
    -------------------------------------------






    Original Message


  • 4.  RE:co-sponsoring JSM sessions

    Posted 04-26-2011 14:21
    Hi All,

    Could someone give some background on what it means to cosponsor a session?
    I assume we are looking at sessions that would be of particular interest to the applied statistician?

    Sorry for my ignorance.

    Thanks,
    Greg

    -------------------------------------------
    Gregory Goodwin
    Research Statistician
    SAS Institute Inc.
    -------------------------------------------






    Original Message


  • 5.  RE:co-sponsoring JSM sessions

    Posted 04-26-2011 14:41
    Hey Greg,

    Thanks for your question.  I must admit that I don't have a good answer - I guess I am just making my own assumptions about what it means.

    To my knowledge, co-sponsoring a session does not make us accountable or give us any responsibilities for the session.  As far as I can tell, co-sponsoring a session gives the attendee the option to search on a committee (section, etc.) and see what all the committee is sponsoring.  So, I don't think we have to be perfect but rather target sessions that may be of interest to applied statisticians.  I guess I think about sessions that sound more like case studies and less like theoretical simulations.

    Do you think that is a good plan?

    Invited sessions have to be sponsored by a section and can be co-sponsored by a committee.  Committees are given one opportunity for an invited session and unfortunately neither of our proposals were awarded an invited session.  I am not sure of rules beyond that.

    What do others think?

    Jennifer


    -------------------------------------------
    Jennifer Gauvin
    Manager, Statistics
    GlaxoSmithKline
    -------------------------------------------






    Original Message


  • 6.  RE:co-sponsoring JSM sessions

    Posted 04-26-2011 15:23

    Hi all,

        I looked through the Contributed Topics in the 2011 JSM Program for Monday, 8/1, and found the following sessions that matched up with CAS's four goals:

    111 Statistical Programmers in the Pharmaceutical Industry
    116 Non-Inferiority Trial Design Issues for Medical Devices
    159 Advances in Adaptive Clinical Trials

    Session 111 has a couple of talks that would be helpful to someone considering the career of statistical programmer.  Session 116 is a practical primer on non-inferiority trials that is generalizable beyond medical devices, and Session 159 is full of examples and practical advice.

     

     

     

     

     

     







    The full program for each session is below:

     


    111 Statistical Programmers in the Pharmaceutical Industry

    Statistical Programmers in the Pharmaceutical Industry - Topic Contributed Papers

    Section for Statistical Programmers and Analysts , Biopharmaceutical Section

    Organizer(s): Jennifer Borkowsky, Genentech

    Chair(s): Jennifer Borkowsky, Genentech

    8:35 AM

    Statistical Programming At Academic And Industrial Settings - Hsin-Yi (Cindy) Weng , Unviersity of Utah, Department of Pediatrics

    8:55 AM

    The Future Of Statistical Analyst'S Work In The Pharmaceutical Industry: Trial Simulation - Natalie Cheung Hall, Eli Lilly and Co.

    9:15 AM

    Becoming A Pharmaceutical Statistical Programmer - Sandra Minjoe, Octagon Research Solutions ; Mario Widel, Roche Molecular Systems, Inc

    9:35 AM

    Agile Approach To Overcome Evolving Challenges Faced By Statistical Programmers During Clinical Reporting - vikash jain, eClinical Solutions

    9:55 AM

    Discussant: Charles Kincaid, COMSYS

    10:15 AM

    Floor Discussion


    116 Non-Inferiority Trial Design Issues for Medical Devices

    Non-Inferiority Trial Design Issues for Medical Devices - Topic Contributed Papers

    Biopharmaceutical Section

    Organizer(s): Heng Li, FDA/CDRH, Hsini Terry Liao, Boston Scientific Corporation

    Chair(s): Vandana Mukhi, FDA/CDRH

    8:35 AM

    Practical Issues In Non-Inferiority Trials - Chul H Ahn, FDA-CDRH

    8:55 AM

    Non-Inferiority Tests For Binomial Endpoints In Two Arm Medical Device Trials - Maria Carola Alfaro, Boston Scientific ; Edmund McMullen, Boston Scientific

    9:15 AM

    Non-Inferiority Testing With A Variable Margin - Yonghong Gao, CDRH/FDA

    9:35 AM

    Binomial Confidence Intervals For Testing Non-Inferiority Or Superiority: A Practitioner'S Dilemma - Vivek Pradhan, Boston Scientific Corp ; John C Evans, Boston Scientific Corp ; Tathagata Banerjee, IIMA

    9:55 AM

    Elicitation Of Non-Inferiority Margin - Xiting (Cindy) Yang, FDA-CDRH

    10:15 AM

    Floor Discussion

     

    159 Advances in Adaptive Clinical Trials

    Advances in Adaptive Clinical Trials - Topic Contributed Papers

    Biopharmaceutical Section , Biometrics Section , ENAR

    Organizer(s): Steven Sun, Johnson & Johnson, Bo Yang, Merck

    Chair(s): TBD TBD, TBD

    10:35 AM

    Monitoring Adaptive Clinical Trials; Case Studies - Zoran Antonijevic, Center for Statistics in Drug Development Innovation, Quintiles

    10:55 AM

    Evaluating The Usefulness Of Adaptive Designs In Practice: Going Beyond Statistical Characteristics - Jose Carlos Pinheiro, Johnson & Johnson PRD ; Chyi-Hung Hsu, Johnson & Johnson PRD

    11:15 AM

    Design And Operational Issues In Clinical Trials With Adaptive Design - Gang Chen, Johnson & Johnson

    11:35 AM

    Adaptive Design: Some Theories And Examples - Xiaolong Luo, Celgene Corporation

    11:55 AM

    Adaptive Design With Some Practical Issues - Bo Yang, Merck

    12:15 PM

    Floor Discussion

     


    Regards,

    Jack 




    -------------------------------------------
    Jack Nyberg
    Sr. Manager
    DEY Pharma L.P.
    -------------------------------------------






    Original Message


  • 7.  RE:co-sponsoring JSM sessions

    Posted 04-26-2011 22:52
    Hi all, Jennifer I can review a day too. Agreed that the idea of co-sponsorship Is about PR for our committee. All relevant presentations should be up for consideration. ------------------------------------------- Erin Tanenbaum] -------------------------------------------
    Original Message


  • 8.  RE:co-sponsoring JSM sessions

    Posted 04-26-2011 23:01
    My understanding of sponsoring of sessions is consistent with what has been said by others that its a way to publicize our committee.  The more quality sessions  the committee's name is associated with the more visibility we get.  I'll be happy to review a day as well.

    Thanks!


    -------------------------------------------
    Amarjot Kaur
    Director
    Merck & Co Inc
    -------------------------------------------






    Original Message


  • 9.  RE:co-sponsoring JSM sessions

    Posted 04-29-2011 14:54

    Of the Tuesday Invited Papers/Panels, there was one session that sounds like one we ourselves would have created:

    385- The World of Statistical Analysis Professionals

    Of the remaining sessions, the ones which feel more applied to me are the following:

    277 Recent developments in addressing multiplicity issues in clinical trials

    316 Complex and massive multiple testing problems

    383  Using paradata for field management, quality assurance, and statistical control




    -------------------------------------------
    Keith Schleicher
    Capital One Services, Inc
    -------------------------------------------






    Original Message


  • 10.  RE:co-sponsoring JSM sessions

    Posted 05-05-2011 13:40
    For Topic Contributed Papers/Contributed Papers for Sunday, below are what I think are candidates.

    Jennifer ... for #70, you are the perfect person to tell me if this qualifies -- seems like this would be of great interest to an applied statistician working in Oncology?

    14 - Clinical Trials: How to Make the Right Decision
    19 - Good Statistical Practice
    32 - Hypothesis Testing
    60 - Statistical Programmers and Statistician Current Challenge, CDSIC
    62 - Statistical Engineering: Creating Sustainable Business Solutions by Integrating Statistics with Science 
    70 - Topics in Oncology Studies  

    If anyone would care to review to see if you think any of these should not be included, I'd appreciate it.

    Thanks,
    Greg


    Original Message


  • 11.  RE:co-sponsoring JSM sessions

    Posted 05-09-2011 16:55
    Hey everyone,  Thanks for your help!  The highlight are the gaps.  Are there any sessions during these times we want to co-sponsor?  Please let me know by EOB tomorrow.  Jennifer



    Invited

    Topic Contributed

    Sun 7/31

    Mark

    Greg

    Mon 8/1

    Amarjot

    Jack

    Tues 8/2

    Keith

    Erin

    Wed 8/3

    Barbara

    Marlene

    Thurs 8/4

    Jennifer

    Jennifer

     

    Sunday July 31

    Topic Contributed/ Contributed
    14 - Clinical Trials: How to Make the Right Decision
    19 - Good Statistical Practice
    32 - Hypothesis Testing
    60 - Statistical Programmers and Statistician Current Challenge, CDSIC
    62 - Statistical Engineering: Creating Sustainable Business Solutions by Integrating Statistics with Science 
    70 - Topics in Oncology Studies  

    Monday August 1

    Topic Contributed

    111 Statistical Programmers in the Pharmaceutical Industry
    116 Non-Inferiority Trial Design Issues for Medical Devices
    159 Advances in Adaptive Clinical Trials

    Tuesday August 2

    Invited

    385- The World of Statistical Analysis Professionals
    277 Recent developments in addressing multiplicity issues in clinical trials
    316 Complex and massive multiple testing problems
    383  Using paradata for field management, quality assurance, and statistical control

    Thursday August 4

    Topic Contributed and Invited

    612

    Issues of Biomarker Testing in Clinical Trials for Personalized Medicine

    658

    Successful Statistical Consulting...

    616

    The World of Applied Statistics: where do YOU fit in? (already CAS sponsored)

    613

    Application of Bayesian Statistics in Medical Device Trials: Design and Analysis

    649

    Improving Designs and Analysis Methodologies in Clinical Trials

    651

    Clinical Trial Designs in US VA Cooperative Studies Program

     




    Original Message